股权激励

Search documents
云从科技: 监事会关于公司2025年限制性股票激励计划预留授予激励对象名单的核查意见(截至预留授予日)
Zheng Quan Zhi Xing· 2025-07-04 16:35
Core Viewpoint - The Supervisory Board of CloudWalk Technology Group Co., Ltd. has reviewed and approved the list of incentive recipients for the 2025 Restricted Stock Incentive Plan, confirming compliance with relevant laws and regulations [1][2]. Group 1: Incentive Plan Overview - The 2025 Restricted Stock Incentive Plan aims to motivate key personnel, excluding independent directors, supervisors, and major shareholders [2]. - The plan includes a total of 1.04 million shares of restricted stock to be granted at a price of 6.58 yuan per share, with the grant date set for July 3, 2025 [2]. Group 2: Eligibility Criteria - The Supervisory Board has established specific criteria for disqualifying potential incentive recipients, including recent sanctions by the stock exchange or the China Securities Regulatory Commission (CSRC) [1]. - The eligibility criteria align with the provisions of the Company Law, Securities Law, and other relevant regulations, ensuring that the selected recipients meet the necessary qualifications [2].
光云科技: 光云科技:董事会薪酬与考核委员会关于2025年限制性股票激励计划首次授予激励对象名单的核查意见(截至授予日)
Zheng Quan Zhi Xing· 2025-07-04 16:34
Core Points - The company has conducted a review of the list of incentive recipients for the 2025 Restricted Stock Incentive Plan, ensuring compliance with relevant laws and regulations [1][2] - The initial grant date for the incentive plan is set for July 4, 2025 [2] Summary by Categories Compliance and Eligibility - The review confirms that the incentive recipients meet the qualifications outlined in the Securities Law, Management Measures, and Listing Rules [2] - Specific disqualifications for incentive recipients include being recognized as inappropriate by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months, or having been penalized for major violations [1] Incentive Plan Details - The incentive plan is aligned with the approved draft and includes shareholders with more than 5% ownership and their immediate family members [2] - The plan adheres to the company's articles of association and relevant regulatory frameworks [2]
九号公司: 九号有限公司关于2022年限制性股票激励计划第三次预留授予部分第二个归属期归属条件成就的公告
Zheng Quan Zhi Xing· 2025-07-04 16:34
《关于向激励对象首次授予 2022 年限制性股票计划对应存托凭证的议案》。公 司独立董事对该事项发表了独立意见,认为首次授予条件已经成就,激励对象 主体资格合法有效,确定的授予日符合相关规定。公司独立董事对首次授予日 的激励对象名单进行核实并发表了核查意见。 《关于向激励对象授予预留部分 2022 年限制性股票对应存托凭证的议案》。公 司独立董事对该事项发表了独立意见,认为预留部分授予条件已经成就,激励 对象主体资格合法有效,确定的授予日符合相关规定。公司独立董事对本次预 留授予的激励对象名单进行核实并发表了核查意见。 《关于向激励对象授予预留部分 2022 年限制性股票对应存托凭证的议案》。公 司独立董事对该事项发表了独立意见,认为预留部分授予条件已经成就,激励 对象主体资格合法有效,确定的授予日符合相关规定。公司独立董事对本次预 留授予的激励对象名单进行核实并发表了核查意见。 《关于向激励对象授予预留部分 2022 年限制性股票对应存托凭证的议案》。公 司独立董事对该事项发表了独立意见,认为预留部分授予条件已经成就,激励 对象主体资格合法有效,确定的授予日符合相关规定。公司独立董事对本次预 留授予的激励对 ...
中国软件: 中国软件第八届董事会第二十一次会议决议公告
Zheng Quan Zhi Xing· 2025-07-04 16:33
证券代码:600536 证券简称:中国软件 公告编号:2025-032 中国软件与技术服务股份有限公司 第八届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 (二)本次董事会会议通知和材料于 2025 年 6 月 25 日以微信方式发出。 (三)本次董事会会议于 2025 年 7 月 4 日,采取了通讯的表决方式。 (四)本次董事会会议应出席董事 7 人,实际出席董事 7 人。其中:以通讯 表决方式出席会议的董事 7 人。 (一)公司第八届董事会第二十一次会议的召开符合有关法律、行政法规、 部门规章、规范性文件和公司章程的规定。 鉴于公司已于 2025 年 2 月 20 日办理完成 2021 年限制性股票激励计划授予的 207,898 股股权激励限制性股票的回购注销,股份总数由 850,170,397 股变更为 849,962,499 股,拟 将公司注册资本由 850,170,397 元变更为 849,962,499 元;公司已于 2025 年 7 月 3 日就向 特 ...
中无人机: 中无人机关于以集中竞价交易方式回购股份的回购报告书
Zheng Quan Zhi Xing· 2025-07-04 16:22
Core Viewpoint - The company plans to repurchase shares through a centralized bidding process, with a total repurchase amount between RMB 100 million and RMB 200 million, aimed at enhancing investor confidence and establishing a long-term incentive mechanism for employees [1][7][10]. Summary by Relevant Sections Repurchase Plan Details - Total repurchase amount: not less than RMB 100 million and not more than RMB 200 million [1][7]. - Source of funds: company’s own funds [9]. - Purpose of repurchase: to be used for employee stock ownership plans or equity incentives; untransferred shares after three years will be canceled [1][7]. - Maximum repurchase price: RMB 60.52 per share, which does not exceed 150% of the average trading price over the previous 30 trading days [1][9]. - Method of repurchase: through the Shanghai Stock Exchange trading system [1][6]. Timeline and Approval - Repurchase period: within 12 months from the approval date by the shareholders' meeting [2][5]. - The repurchase proposal was approved at the first extraordinary shareholders' meeting on June 26, 2025 [2][5]. Shareholder Actions - Major shareholders have confirmed no current plans for share reduction, with one major shareholder having completed a reduction plan on June 9, 2025 [2][12]. - The chairman and vice-chairman plan to increase their shareholdings during the repurchase period [3][11]. Financial Impact - The repurchase is expected to have a minimal impact on the company's financials, with the maximum repurchase amount representing only 2.29% of total assets and 3.52% of net assets [10]. - The company's debt ratio is 34.86%, indicating that the repurchase will not significantly affect its debt servicing ability [10]. Future Share Structure - The repurchase is projected to reduce the total share capital by approximately 0.24% to 0.49%, depending on the final number of shares repurchased [7][8]. Compliance and Governance - The company has established a dedicated repurchase account and will comply with all relevant regulations during the repurchase process [17]. - The board of directors has been authorized to manage the repurchase details, including timing and pricing adjustments as necessary [15].
康美药业: 广东信达律师事务所关于康美药业股份有限公司股权激励限制性股票回购注销实施的法律意见书
Zheng Quan Zhi Xing· 2025-07-04 16:22
康美药业股份有限公司 股权激励限制性股票回购注销实施的 法律意见书 中国 深圳 益田路6001号太平金融大厦11、12楼 邮政编码:518038 电话(Tel):(0755)88265288 传真(Fax):(0755) 88265537 电子邮件(E-mail):info@sundiallawfirm.com 网站(Website):www.sundiallawfirm.com 法律意见书 目 录 法律意见书 广东信达律师事务所 关于康美药业股份有限公司 股权激励限制性股票回购注销实施的 法律意见书 关于 《公司章程》")、 《康美药业股 份有限公司第一期限制性股票激励计划(草案)》(以下简称"《第一期激励计划 (草案)》")、《康美药业股份有限公司第二期限制性股票激励计划(草案)》(以 下简称"《第二期激励计划(草案)》")的规定,就公司回购注销第一期限制性股 票激励计划(以下简称"第一期股权激励计划")尚未解锁的限制性股票及第二 期限制性股票激励计划(以下简称"第二期股权激励计划")的限制性股票(以 下简称"本次回购注销")所涉及的相关事项,出具本法律意见书。 信达是在中华人民共和国合法注册并具有中华人 ...
实控人通过合伙企业间接持股IPO公司的高税负问题(20案例)
梧桐树下V· 2025-07-04 11:57
实践中,大多数IPO企业都会设立股权激励的持股平台, 主要的组织形式为有限合伙企业的形式, 甚至也存 在实控人在持股平台(有限合伙企业)中持有较高份额的情况。也因此,在实际工作中,无论是投行、会计 师、律师、还是拟IPO企业的董秘、财务总监等,都将面临一系列与合伙企业息息相关的涉税难点与争议。 那么,合伙企业在日常税务处理中有哪些难点呢?其中,又有哪些问题是你正在经历和思考的? 难点1: 合伙企业产生了利润但未做实际分配,合伙人是否不用计缴所得税?如何理解合伙企业的"先分后 税"? 难点2: 合伙协议可约定将全部利润分配给部分合伙人吗? 难点3: 多层合伙架构中利息、股息、红利所得如何纳税?纳税义务时间? 难点4: 合伙企业取得股息红利收益,再分配给法人合伙人,法人合伙人是否享受居民企业股息红利免税政 策? 难点5: 合伙企业自然人合伙人从A股取得股息所得是否可享受免征个人所得税? 难点6: 被投资企业资本公积转增股本,合伙企业合伙人按"股息红利"缴纳了个税,后续合伙企业合伙人转 让合伙份额,该份额对应的成本如何认定?针对被投资企业资本公积转增股本对应合伙企业已缴纳个税的投 资或收益金额,能否作为下次转让时的 ...
聚灿光电(300708):公司业绩稳健增长,股份用途变更+股权激励彰显长期发展信心
Shanxi Securities· 2025-07-04 07:35
LED 聚灿光电(300708.SZ) 买入-A(维持) 公司业绩稳健增长,股份用途变更+股权激励彰显长期发展信心 2025 年 7 月 4 日 公司研究/公司快报 | 市场数据:2025 年 月 7 | 日 3 | | --- | --- | | 收盘价(元): | 12.17 | | 年内最高/最低(元): | 15.38/7.63 | | 流通A股/总股本(亿): | 5.22/6.80 | | 流通 A 股市值(亿): | 63.56 | | 总市值(亿): | 82.77 | | 基础数据:2025 年 | 3 月 | 31 | 日 | | | --- | --- | --- | --- | --- | | 基本每股收益(元): | | | | 0.09 | | 摊薄每股收益(元): | | | | 0.09 | | 每股净资产(元): | | | | 3.96 | | 净资产收益率(%): | | | | 2.30 | 公司近一年市场表现 事件描述 高宇洋 邮箱:dongwendan@sxzq.com 2025 年 6 月 17 日,聚灿光电发布《关于变更回购股份用途并注销暨减 少注册资本的公告》 ...
法本信息: 北京市君泽君(上海)律师事务所关于深圳市法本信息技术股份有限公司2023年限制性股票与股票期权激励计划调整授予价格及行权价格、作废部分限制性股票及注销部分股票期权事项之法律意见书
Zheng Quan Zhi Xing· 2025-07-03 16:27
Core Viewpoint - The legal opinion letter from Junzejun Law Firm outlines the adjustments to the grant price and exercise price of stock options and the cancellation of certain restricted stocks and stock options for Shenzhen Fabon Information Technology Co., Ltd. as part of its 2023 incentive plan [1][2][12]. Summary by Sections Approval and Authorization of Adjustments and Cancellations - The company has completed necessary procedures for the adjustments and cancellations, including approvals from the board of directors and the supervisory board on multiple dates in 2023 and 2024 [5][6][7][8][9][10][11][12][15]. Details of the Adjustments - The adjustments were made in response to a cash dividend distribution approved by the shareholders, where the company will distribute 0.65 RMB per 10 shares, leading to a reduction in the grant and exercise prices [12][13]. - The adjusted grant price for restricted stocks is approximately 7.28 RMB per share, and the adjusted exercise price for stock options is approximately 14.73 RMB per share [13][14]. Cancellations of Restricted Stocks and Stock Options - The cancellation of restricted stocks and stock options is due to the departure of one incentive object, resulting in the cancellation of 8,478 shares of restricted stock and 8,478 stock options [14][15]. - The company has followed the required procedures for these cancellations, which do not require further shareholder approval [15]. Information Disclosure - The company has fulfilled its information disclosure obligations regarding the adjustments and cancellations, and will continue to disclose relevant information as required by laws and regulations [15][16].
法本信息: 关于调整2023年限制性股票与股票期权激励计划授予价格及行权价格的公告
Zheng Quan Zhi Xing· 2025-07-03 16:27
Core Viewpoint - The company has announced adjustments to the grant price and exercise price of its 2023 restricted stock and stock option incentive plan, following necessary approvals and procedures [1][4][7]. Summary by Sections Approval Procedures - The incentive plan underwent several approval steps, including reviews by the compensation and assessment committee, board of directors, and supervisory board, all of which were completed by May 31, 2023 [2][3]. - The company held a temporary shareholders' meeting on June 19, 2023, where the incentive plan was approved [3]. Adjustment Details - The adjustment of the grant price and exercise price was necessitated by the completion of the 2024 annual equity distribution on May 30, 2025, which involved a cash dividend of 0.65 RMB per 10 shares [5][6]. - The adjusted grant price for restricted stock is approximately 7.28 RMB per share, and the adjusted exercise price for stock options is approximately 14.73 RMB per share [6]. Impact on the Company - The adjustments comply with relevant regulations and will not materially affect the company's financial status or operational results [6][7]. Supervisory Board Opinion - The supervisory board agrees that the adjustments are in line with legal and regulatory requirements and do not harm the interests of the company or its shareholders [7]. Legal Opinion - The legal firm has confirmed that the adjustments and cancellations have received necessary approvals and comply with applicable laws and regulations [7][8].